FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1809024175> ?p ?o ?g. }

• W1809024175 endingPage "62" @default.
• W1809024175 startingPage "556" @default.
• W1809024175 abstract "P53 status may be a determinant of chemosensitivity of tumor cells; however, its involvement in cellular resistance to cisplatin remains uncertain. To investigate the relationships between p53 and the development of resistance to cisplatin, the p53 gene status was studied in ovarian carcinoma cell systems which included two cisplatin-resistant variants (IGROV-1/Pt 0.5 and IGROV-1/Pt 1) selected in vitro after prolonged drug exposure of the cisplatin-sensitive parental IGROV-1 cell line. IGROV-1/Pt 0.5 and IGROV-1/Pt 1 cell lines exhibited a degree of resistance of approximately 6 and 14, respectively, following 96-h exposure to the drug and were cross-resistant to other DNA-damaging agents (ionizing radiation and melphalan). Resistance to cisplatin paralleled a reduced cell susceptibility to cisplatin-induced apoptosis. DNA single-strand conformation polymorphism analysis of exons 5-9 demonstrated the presence of two mutants alleles at exon 8 in the two resistant cell lines, in contrast to the parental IGROV-1 cell line which exhibited the wild-type p53 gene. Direct DNA sequencing revealed that the mutations consist of two nucleotide changes in the DNA-binding domain at codons 270 (T/A) and 282 (C/T). The consecutive levels of p53 protein were lower in IGROV-1 than in IGROV-1/Pt cells. Following exposure to ionizing radiation or cisplatin, accumulation of the p53 protein was markedly enhanced only in the sensitive cells. Concomitantly, the expression of WAF-1 protein was strongly induced in the parental IGROV-1 cells, whereas WAF-1 protein remained undetectable in the IGROV-1/Pt 1 subline after DNA-damaging treatment. Consistent with this finding is the observation that ionizing radiation caused a different pattern of cell cycle perturbation in sensitive and resistant cells. Northern blot analysis demonstrated a marked reduction in bax mRNA levels in IGROV-1/Pt 1 cisplatin-resistant cells. Cotransfection assays with wild-type or mutant p53 expression plasmids and a reporter gene plasmid that utilized the bax gene promoter to drive transcription of chloramphenicol acetyltransferase were consistent with the role of p53 in regulation of bax expression in these cells. Taken together, these observations support a role for mutations of the p53 gene in the development of cisplatin resistance in ovarian cancer as a consequence of loss of the ability of p53 to transactivate bax, an apoptosis-inducing gene." @default.
• W1809024175 created "2016-06-24" @default.
• W1809024175 creator A5019799584 @default.
• W1809024175 creator A5033312783 @default.
• W1809024175 creator A5033689092 @default.
• W1809024175 creator A5041620597 @default.
• W1809024175 creator A5048820442 @default.
• W1809024175 creator A5052204789 @default.
• W1809024175 creator A5056175990 @default.
• W1809024175 creator A5059438505 @default.
• W1809024175 creator A5070863361 @default.
• W1809024175 creator A5080261722 @default.
• W1809024175 date "1996-02-01" @default.
• W1809024175 modified "2023-10-16" @default.
• W1809024175 title "Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems." @default.
• W1809024175 cites W1498586399 @default.
• W1809024175 cites W1518376386 @default.
• W1809024175 cites W1552426876 @default.
• W1809024175 cites W1583547469 @default.
• W1809024175 cites W1654947539 @default.
• W1809024175 cites W1977686001 @default.
• W1809024175 cites W1987437563 @default.
• W1809024175 cites W2004969496 @default.
• W1809024175 cites W2016859145 @default.
• W1809024175 cites W2026456619 @default.
• W1809024175 cites W2043912950 @default.
• W1809024175 cites W2070461153 @default.
• W1809024175 cites W2074598863 @default.
• W1809024175 cites W2078003307 @default.
• W1809024175 cites W2078144803 @default.
• W1809024175 cites W2078988395 @default.
• W1809024175 cites W2081894694 @default.
• W1809024175 cites W2092200570 @default.
• W1809024175 cites W2100837269 @default.
• W1809024175 cites W2103936018 @default.
• W1809024175 cites W2127952872 @default.
• W1809024175 cites W2134979684 @default.
• W1809024175 cites W2158874806 @default.
• W1809024175 cites W2339809149 @default.
• W1809024175 cites W2397241885 @default.
• W1809024175 cites W2399587269 @default.
• W1809024175 cites W2413760962 @default.
• W1809024175 cites W2417643957 @default.
• W1809024175 cites W2433711353 @default.
• W1809024175 cites W3121869049 @default.
• W1809024175 cites W35717447 @default.
• W1809024175 cites W994887766 @default.
• W1809024175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8564971" @default.
• W1809024175 hasPublicationYear "1996" @default.
• W1809024175 type Work @default.
• W1809024175 sameAs 1809024175 @default.
• W1809024175 citedByCount "145" @default.
• W1809024175 countsByYear W18090241752012 @default.
• W1809024175 countsByYear W18090241752013 @default.
• W1809024175 countsByYear W18090241752014 @default.
• W1809024175 countsByYear W18090241752015 @default.
• W1809024175 countsByYear W18090241752016 @default.
• W1809024175 countsByYear W18090241752017 @default.
• W1809024175 countsByYear W18090241752018 @default.
• W1809024175 countsByYear W18090241752019 @default.
• W1809024175 countsByYear W18090241752020 @default.
• W1809024175 countsByYear W18090241752021 @default.
• W1809024175 countsByYear W18090241752022 @default.
• W1809024175 countsByYear W18090241752023 @default.
• W1809024175 crossrefType "journal-article" @default.
• W1809024175 hasAuthorship W1809024175A5019799584 @default.
• W1809024175 hasAuthorship W1809024175A5033312783 @default.
• W1809024175 hasAuthorship W1809024175A5033689092 @default.
• W1809024175 hasAuthorship W1809024175A5041620597 @default.
• W1809024175 hasAuthorship W1809024175A5048820442 @default.
• W1809024175 hasAuthorship W1809024175A5052204789 @default.
• W1809024175 hasAuthorship W1809024175A5056175990 @default.
• W1809024175 hasAuthorship W1809024175A5059438505 @default.
• W1809024175 hasAuthorship W1809024175A5070863361 @default.
• W1809024175 hasAuthorship W1809024175A5080261722 @default.
• W1809024175 hasConcept C104317684 @default.
• W1809024175 hasConcept C153911025 @default.
• W1809024175 hasConcept C2776694085 @default.
• W1809024175 hasConcept C2778239845 @default.
• W1809024175 hasConcept C36823959 @default.
• W1809024175 hasConcept C502942594 @default.
• W1809024175 hasConcept C54355233 @default.
• W1809024175 hasConcept C81885089 @default.
• W1809024175 hasConcept C86803240 @default.
• W1809024175 hasConceptScore W1809024175C104317684 @default.
• W1809024175 hasConceptScore W1809024175C153911025 @default.
• W1809024175 hasConceptScore W1809024175C2776694085 @default.
• W1809024175 hasConceptScore W1809024175C2778239845 @default.
• W1809024175 hasConceptScore W1809024175C36823959 @default.
• W1809024175 hasConceptScore W1809024175C502942594 @default.
• W1809024175 hasConceptScore W1809024175C54355233 @default.
• W1809024175 hasConceptScore W1809024175C81885089 @default.
• W1809024175 hasConceptScore W1809024175C86803240 @default.
• W1809024175 hasIssue "3" @default.
• W1809024175 hasLocation W18090241751 @default.
• W1809024175 hasOpenAccess W1809024175 @default.
• W1809024175 hasPrimaryLocation W18090241751 @default.
• W1809024175 hasRelatedWork W136468098 @default.

• next